Jabra Enhance Pro 20 at Costco vs Otofonix Groove

The Jabra Enhance Pro 20 at Costco is a behind-the-ear prescription hearing aid priced at $1,600, placing it in the premium tier. With a SoundScore of 4.0/5 and an A grade, it ranks #25 of 39 prescription hearing aids tested in our lab. In our testing, this device demonstrates notable strengths in own-voice comfort, scoring 3.5/5—0.80 points above the category average. This solid performance means wearers may find their own voice sounds more natural compared to many competitors. Feedback handling is excellent at 4.8/5, slightly above the category average, indicating reliable stability during movement and phone use. However, the Enhance Pro 20 shows limitations in challenging listening environments. Speech-in-noise performance scores just 1.1/5, falling 0.97 points below the category average—a significant gap that may affect conversations in restaurants, social gatherings, or other noisy settings. Speech-in-quiet is solid at 3.2/5 in absolute terms, though still 0.17 points below the category average. Music streaming scores 2.8/5, which is above the category average but only mixed in absolute terms. This device suits users who prioritize comfortable own-voice perception and excellent feedback control, and who spend most listening time in quieter environments. Those frequently navigating noisy situations may want to consider alternatives like the Rexton Reach R-Li T80 at Costco, which scored 4.56/5 in our testing. The Enhance Pro 20 includes rechargeable batteries, iPhone and Android streaming, and hands-free functionality.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.